Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal

Francis I. Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, CA, USA.
Bulletin of the World Health Organisation (Impact Factor: 5.09). 02/2001; 79(3):194-200. DOI: 10.1590/S0042-96862001000300006
Source: PubMed


The study compares the effectiveness of two strategies for distributing azithromycin in an area with mild-to-moderate active trachoma in Nepal.
The two strategies investigated were the use of azithromycin for 1) mass treatment of all children, or 2) targeted treatment of only those children who were found to be clinically active, as well as all members of their household.
Mass treatment of children was slightly more effective in terms of decreasing the prevalence of clinically active trachoma (estimated by clinical examination) and of chlamydial infection (estimated by DNA amplification tests), although neither result was statistically significant.
Both strategies appeared to be effective in reducing the prevalence of clinically active trachoma and infection six months after the treatment. Antibiotic treatment reduced the prevalence of chlamydial infection more than it did the level of clinically active trachoma.

Download full-text


Available from: Ramesh Bhatta,
  • Source
    • "All people living in a household containing an individual with active disease (Holm et al. 2001; Burton et al. 2003; Blake et al. 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Trachoma is the commonest infectious cause of blindness. Recurrent episodes of infection with serovars A-C of Chlamydia trachomatis cause conjunctival inflammation in children who go on to develop scarring and blindness as adults. It was estimated that in 2002 at least 1.3 million people were blind from trachoma, and currently 40 million people are thought to have active disease and 8.2 million to have trichiasis. The disease is largely found in poor, rural communities in developing countries, particularly in sub-Saharan Africa. The WHO promotes trachoma control through a multifaceted approach involving surgery, mass antibiotic distribution, encouraging facial cleanliness and environmental improvements. This has been associated with significant reductions in the prevalence of active disease over the past 20 years, but there remain a large number of people with trichiasis who are at risk of blindness.
    Tropical Medicine & International Health 04/2010; 15(6):673-91. DOI:10.1111/j.1365-3156.2010.02521.x · 2.33 Impact Factor
  • Source
    • "The finding in this setting (and others) of householdclustering suggests control programmes involving delivery of antibiotics may be more cost-effective if they are targeted at households in which active trachoma is found. A randomized trial conducted in Nepal to evaluate this hypothesis suggested that mass treatment of all children was at least as effective and no more expensive than treatment only of children with active disease plus members of their households (Frick et al., 2001; Holm et al., 2001), but such comparisons should be made in other trachoma-endemic areas too. The spatial distribution of active trachoma was also explored in this study. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The distribution of active trachoma in Kahe Mpya, Tanzania, an endemic village of approximately 1000 people, was mapped spatially and analysed for associated risk factors and evidence of clustering. An association between distance to water source and active disease was demonstrated, although this was reduced after accounting for the lack of independence between cases in the same household. Significant clustering of active trachoma within households was demonstrated, adding support to the hypothesized importance of intra-familial transmission. The spatial distribution of trachoma was analysed using the spatial scan statistic, and evidence of clustering of active trachoma cases detected. Understanding the distribution of the disease has implications for understanding the dynamics of transmission and therefore appropriate control activities. The demonstrated spatial clustering suggests inter-familial as well as intra-familial transmission of infection may be common in this setting. The association between active trachoma and geographical information system (GIS) measured distance to water may be relevant for planning control measures.
    Transactions of the Royal Society of Tropical Medicine and Hygiene 04/2005; 99(3):218-25. DOI:10.1016/j.trstmh.2004.06.010 · 1.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Trachoma, a recurrent follicular conjunctivitis caused by Chlamydia trachomatis, is the leading cause of preventable blindness worldwide. Efforts to control this disease have met with limited success. This failure is due in part to the limitations of conventional antibiotic treatment, a prolonged course of topical tetracycline. Azithromycin, an azalide antibiotic, is effective against chlamydial infections when given as a single oral dose. Recent research from Africa has shown azithromycin to be as effective as tetracycline in the treatment of trachoma. Under operational conditions azithromycin proved to be more effective. This success is attributed to a much-improved compliance with treatment. Community-wide mass treatment with azithromycin is advocated as a means of controlling trachoma in endemic countries. Questions still remain over the use of azithromycin for this purpose. The frequency and target population of mass distribution campaigns need to be defined. A few countries are beneficiaries of a philanthropic donation by the manufacturer of azithromycin, Pfizer Inc. However, in the absence of a drug donation programme the cost-effectiveness of this measure is unclear.
    Expert Opinion on Pharmacotherapy 03/2002; 3(2):113-20. DOI:10.1517/14656566.3.2.113 · 3.53 Impact Factor
Show more